Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY – Get Free Report) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totaling 18,708 shares, a decline of 32.6% from the November 30th total of 27,751 shares. Based on an average daily trading volume, of 54,765 shares, the short-interest ratio is presently 0.3 days. Based on an average daily trading volume, of 54,765 shares, the short-interest ratio is presently 0.3 days.
Sinopharm Group Price Performance
Shares of Sinopharm Group stock opened at $12.52 on Tuesday. Sinopharm Group has a 52-week low of $10.72 and a 52-week high of $14.13. The company’s fifty day moving average price is $12.85 and its two-hundred day moving average price is $12.29.
Sinopharm Group Company Profile
Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.
In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.
Featured Articles
- Five stocks we like better than Sinopharm Group
- Wall Street Stockpicker Names #1 Stock of 2026
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Your “birthright claim” just got activated
- Turn your “dead money” into $306+ monthly (starting this month)
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
